Quentin Liu

15.6k total citations · 1 hit paper
163 papers, 6.1k citations indexed

About

Quentin Liu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Quentin Liu has authored 163 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 49 papers in Oncology and 43 papers in Cell Biology. Recurrent topics in Quentin Liu's work include Microtubule and mitosis dynamics (39 papers), Epigenetics and DNA Methylation (20 papers) and Cancer-related Molecular Pathways (18 papers). Quentin Liu is often cited by papers focused on Microtubule and mitosis dynamics (39 papers), Epigenetics and DNA Methylation (20 papers) and Cancer-related Molecular Pathways (18 papers). Quentin Liu collaborates with scholars based in China, United States and United Kingdom. Quentin Liu's co-authors include Min Yan, Jie Xu, Zi-Jie Long, Fei-Meng Zheng, Xiang‐Bo Wan, Zi‐Jie Long, Eric W.‐F. Lam, Joan Ruderman, Fei Peng and Bin He and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Quentin Liu

159 papers receiving 6.1k citations

Hit Papers

STAT5 promotes PD-L1 expression by facilitating histone l... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quentin Liu China 47 3.7k 1.7k 1.5k 1.3k 785 163 6.1k
Rakesh Kumar United States 47 4.6k 1.2× 2.2k 1.3× 1.2k 0.8× 816 0.6× 483 0.6× 160 7.1k
Frank A.E. Kruyt Netherlands 50 5.7k 1.5× 2.3k 1.4× 1.7k 1.1× 757 0.6× 739 0.9× 140 7.9k
Elena Feinstein United States 40 4.2k 1.1× 1.2k 0.7× 1.1k 0.7× 656 0.5× 501 0.6× 63 6.7k
Ceshi Chen China 49 5.2k 1.4× 1.6k 1.0× 1.6k 1.0× 656 0.5× 316 0.4× 182 6.8k
Murray D. Norris Australia 46 4.8k 1.3× 3.1k 1.9× 1.6k 1.0× 795 0.6× 500 0.6× 197 8.2k
Marco Falasca Australia 51 5.4k 1.4× 2.1k 1.2× 1.1k 0.8× 1.6k 1.2× 481 0.6× 183 8.7k
Zhenkun Lou United States 53 6.8k 1.8× 2.8k 1.7× 1.4k 0.9× 880 0.7× 1.0k 1.3× 134 9.0k
Jeffrey P. MacKeigan United States 32 4.4k 1.2× 969 0.6× 1.4k 0.9× 732 0.6× 848 1.1× 62 6.5k
Kevin M. Haigis United States 42 3.9k 1.0× 2.5k 1.5× 1.0k 0.7× 713 0.6× 581 0.7× 105 6.8k
Nathan R. Wall United States 37 5.1k 1.4× 1.8k 1.1× 1.4k 0.9× 493 0.4× 697 0.9× 99 7.5k

Countries citing papers authored by Quentin Liu

Since Specialization
Citations

This map shows the geographic impact of Quentin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quentin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quentin Liu more than expected).

Fields of papers citing papers by Quentin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quentin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quentin Liu. The network helps show where Quentin Liu may publish in the future.

Co-authorship network of co-authors of Quentin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Quentin Liu. A scholar is included among the top collaborators of Quentin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quentin Liu. Quentin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Fei, et al.. (2025). Integrating cancer medicine into metabolic rhythms. Trends in Endocrinology and Metabolism. 36(11). 1014–1028. 2 indexed citations
2.
Zhang, Lixing, Juchuanli Tu, Siqin Li, et al.. (2024). IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. Cancer Research. 84(14). 2282–2296. 26 indexed citations
3.
Liu, Fang, Nana Chen, Xin‐Hao Li, et al.. (2024). AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis. Cell Death and Disease. 15(3). 233–233. 6 indexed citations
4.
Cui, Bai, Bin He, Yanping Huang, et al.. (2023). Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress. Cell Death and Disease. 14(10). 682–682. 17 indexed citations
5.
Wang, Lina, Kai Wang, Na Wang, et al.. (2023). Spermine enhances antiviral and anticancer responses by stabilizing DNA binding with the DNA sensor cGAS. Immunity. 56(2). 272–288.e7. 26 indexed citations
6.
7.
Yue, Caifeng, Chang Wang, Jiewei Chen, et al.. (2023). TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer Science. 114(8). 3176–3189. 6 indexed citations
8.
Zhang, Zijian, Wei Zhang, & Quentin Liu. (2022). Fine-tuning cell organelle dynamics during mitosis by small GTPases. Frontiers of Medicine. 16(3). 339–357. 1 indexed citations
9.
Wang, Lina, Kai Wang, Na Wang, et al.. (2022). DNA mechanical flexibility controls DNA potential to activate cGAS-mediated immune surveillance. Nature Communications. 13(1). 7107–7107. 20 indexed citations
10.
Cai, Wei, Mengyan Hu, Chunyi Li, et al.. (2022). FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation. Autophagy. 19(4). 1144–1163. 60 indexed citations
11.
Sun, Shulan, Wei Zhou, Xiaoxi Li, et al.. (2021). Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer. Cancer Communications. 41(9). 851–866. 33 indexed citations
12.
Wen, Shijun, Fang Liu, Zijian Zhang, et al.. (2021). CRISPR/Cas9 screening identifies a kinetochore‐microtubule dependent mechanism for Aurora‐A inhibitor resistance in breast cancer. Cancer Communications. 41(2). 121–139. 30 indexed citations
13.
Wang, Bi‐Cheng, et al.. (2020). Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis. Photodiagnosis and Photodynamic Therapy. 29. 101667–101667. 25 indexed citations
14.
Chen, Jin, Anhui Wang, Bing Liu, et al.. (2019). Quantitative Lysine Reactivity Profiling Reveals Conformational Inhibition Dynamics and Potency of Aurora A Kinase Inhibitors. Analytical Chemistry. 91(20). 13222–13229. 16 indexed citations
15.
Zheng, Fei-Meng, Caifeng Yue, Guohui Li, et al.. (2016). Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nature Communications. 7(1). 10180–10180. 146 indexed citations
16.
Yang, Na, Chang Wang, Min Yan, et al.. (2016). Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer. Cellular Physiology and Biochemistry. 38(3). 1157–1170. 40 indexed citations
17.
Long, Zi-Jie, et al.. (2013). Inhibition of mTOR Pathway Sensitizes Acute Myeloid Leukemia Cells to Aurora Inhibitors by Suppression of Glycolytic Metabolism. Molecular Cancer Research. 11(11). 1326–1336. 59 indexed citations
18.
Dong, Min, Xiang‐Bo Wan, Wei Li, et al.. (2013). Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Medical Oncology. 30(1). 355–355. 43 indexed citations
19.
Wang, Lihui, Jin Xiang, Min Yan, et al.. (2010). The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway. Cancer Research. 70(22). 9118–9128. 107 indexed citations
20.
Guan, Zhong, Xiao‐Feng Zhu, Jie Xu, et al.. (2007). Aurora-A, a Negative Prognostic Marker, Increases Migration and Decreases Radiosensitivity in Cancer Cells. Cancer Research. 67(21). 10436–10444. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026